Evidence map›Paper›PMID 29973246›Full record

ArticleStem cell research & therapy2018

Bioluminescence imaging visualizes osteopontin-induced neurogenesis and neuroblast migration in the mouse brain after stroke.

Rebecca Rogall, Monika Rabenstein, Sabine Vay, Annika Bach, Anton Pikhovych, Johannes Baermann, Mathias Hoehn, Sébastien Couillard-Despres, Gereon Rudolf Fink, Michael Schroeter and 1 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. TheNeural regeneration research · 2021
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Osteopontin Attenuates Secondary Neurodegeneration in the Thalamus after Experimental Stroke.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2019
    Article
  14. Article
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Rebecca RogallDepartment of Neurology, University Hospital of Cologne, Kerpener Strasse 62, 50924, Cologne, Germany.
Monika RabensteinDepartment of Neurology, University Hospital of Cologne, Kerpener Strasse 62, 50924, Cologne, Germany.
Sabine VayDepartment of Neurology, University Hospital of Cologne, Kerpener Strasse 62, 50924, Cologne, Germany.
Annika BachDepartment of Neurology, University Hospital of Cologne, Kerpener Strasse 62, 50924, Cologne, Germany.
Anton PikhovychDepartment of Neurology, University Hospital of Cologne, Kerpener Strasse 62, 50924, Cologne, Germany.
Johannes BaermannDepartment of Neurology, University Hospital of Cologne, Kerpener Strasse 62, 50924, Cologne, Germany.
Mathias HoehnMax Planck Institute for Metabolism Research, Cologne, Germany.
Sébastien Couillard-DespresInstitute of Experimental Neuroregeneration, Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University, Salzburg, Austria.
Gereon Rudolf FinkDepartment of Neurology, University Hospital of Cologne, Kerpener Strasse 62, 50924, Cologne, Germany.
Michael SchroeterDepartment of Neurology, University Hospital of Cologne, Kerpener Strasse 62, 50924, Cologne, Germany.
Maria Adele RuegerDepartment of Neurology, University Hospital of Cologne, Kerpener Strasse 62, 50924, Cologne, Germany. maria.rueger@uk-koeln.de.ORCID 0000-0001-8036-395X
Max Planck Institute for Metabolism Research · DEForschungszentrum Jülich · DEUniversity Hospital Cologne · DEParacelsus Medical University · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteopontin (OPN), an acidic phosphoglycoprotein, is upregulated in the brain after cerebral ischemia. We previously reported that OPN supports migration, survival, and proliferation of neural stem cells (NSC) in primary cell culture, as well as their differentiation into neurons. We here analyzed the effects of OPN on neuroblasts in vivo in the context of cerebral ischemia.

methodsTransgenic mice expressing luciferase under the control of the neuroblast-specific doublecortin (DCX)-promoter, allowing visualization of neuroblasts in vivo using bioluminescence imaging (BLI), were injected with OPN intracerebroventricularly while control mice were injected with vehicle buffer. To assess the effects of OPN after ischemia, additional mice were subjected to photothrombosis and injected with either OPN or vehicle.

resultsOPN enhanced the migration of neuroblasts both in the healthy brain and after ischemia, as quantified by BLI in vivo. Moreover, the number of neural progenitors was increased following OPN treatment, with the maximum effect on the second day after OPN injection into the healthy brain, and 14 days after OPN injection following ischemia. After ischemia, OPN quantitatively promoted the endogenous, ischemia-induced neuroblast expansion, and additionally recruited progenitors from the contralateral hemisphere.

conclusionsOur results strongly suggest that OPN constitutes a promising substance for the targeted activation of neurogenesis in ischemic stroke.

Indexed as

AnimalsBrainCell DifferentiationCell MovementDoublecortin ProteinMagnetic Resonance ImagingMaleMiceMice, TransgenicNeurogenesisOsteopontinStrokeDcx protein, mouseDoublecortin ProteinOsteopontinDoublecortinMicrogliaNeural progenitor cellsPhotothrombosis

Identifiers

PMID29973246
PMCPMC6032781
OpenAlexW2809773816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.